Fasteris

Fasteris is a private, revenue-generating contract service organization (CRO) focused on providing sequencing and genomic analysis services. Its core business model is built on offering reliable, ready-to-run NGS and Sanger sequencing solutions, primarily serving academic, pharmaceutical, and diagnostic clients. The company leverages its established technological infrastructure and quality systems to deliver data for research and diagnostic development. While not developing its own therapeutics or diagnostics, Fasteris occupies a critical niche in the genomics value chain as an essential service provider.

Integrated service platform offering Next-Generation Sequencing (NGS) and Sanger sequencing, including library preparation, sequencing, and bioinformatics data analysis. Holds patents related to its sequencing service methodologies.

Fasteris competes in a crowded field that includes large global CROs (e.g., Eurofins, Quintara), other specialized sequencing service providers, and university core facilities. Its differentiation is based on quality, customer service, integrated bioinformatics, and its position as a European specialist. It must compete on both technical capability and cost-effectiveness.